首页|ATAD2在不同病变肝组织中的表达及意义

ATAD2在不同病变肝组织中的表达及意义

扫码查看
目的 探讨三磷酸腺苷酶家族蛋白2(ATAD2)在不同病变肝组织中的表达及临床意义.方法 收集2011年4月2日 2016年5月29日青岛大学附属医院病理科保存的经手术切除的肝脏不同病变标本180例,采用免疫组织化学方法检测ATAD2的表达.比较不同病变肝组织中ATAD2的表达水平,分析ATAD2在肝细胞肝癌中表达与临床病理特征之间的关系.结果 60例肝细胞肝癌手术标本中有56例(93.33%)表达ATAD2,平均表达量为(24.87±22.21)%;20例胆管细胞癌手术标本中有17例(85.00%)表达ATAD2,平均表达量为(21.45±19.69)%;4例肝脏高级别异型增生结节组织ATAD2平均表达量为(1.00±0.70)%;在肝脏低级别异型增生结节、肝腺瘤、肝局灶增生结节、肝硬化及正常肝组织中均无ATAD2表达.肝细胞肝癌组织ATAD2的平均表达量明显高于肝脏异型增生结节、肝腺瘤、肝局灶增生结节、肝硬化以及正常肝组织,差异具有统计学意义(F=24.45,q=7.37~13.36,P<0.01),而肝细胞肝癌和胆管细胞癌组织ATAD2的表达率和平均表达量差异均无显著性(P>0.05).在56例表达ATAD2的肝细胞肝癌病人手术标本中有52例(92.86%)平均表达量≥3%,50例(89.29%)平均表达量≥5%;在38例病理分级为Ⅰ~Ⅱ级的肝细胞肝癌手术标本中,有35例(92.11%)ATAD2的平均表达量≥1%,31例(81.58%)平均表达量≥3%,29例(76.32%)平均表达量≥5%.ATAD2在肝细胞肝癌中的表达水平与病人血清甲胎蛋白水平、是否携带乙型肝炎病毒表面抗原以及是否合并肝硬化有关(t=2.09~2.30,P<0.05).结论 ATAD2在肝细胞肝癌组织中呈高表达,可能在其发生中起重要作用,并可能参与了细胞的恶性转化过程.ATAD2表达检测对临床判断肝脏病变组织的性质具有较高的参考价值.
EXPRESSION OF ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 2 IN TISSUES OF DIFFERENT LIVER DISEASES AND ITS CLINICAL SIGNIFICANCE
Objective To investigate the expression of ATPase family AAA domain-containing protein 2 (ATAD2) in the tissues of different liver diseases and its clinical significance.Methods A total of 180 samples of different liver lesions obtained by surgical resection and stored in Department of Pathology in The Affiliated Hospital of Qingdao University from April 2,2011 to May 29,2016 were collected,and immunohistochemistry was used to measure the expression of ATAD2.The expression of ATAD2 was compared between the tissues of different liver diseases,and the association between ATAD2 expression in hepatocellular carcinoma and clinicopathological features was analyzed.Results Of all 60 surgical specimens of hepatocellular carcinoma,56 (93.33%) had a mean ATAD2 expression level of (24.87+±22.21) %.Of all 20 surgical specimens of cholangiocellular carcinoma,17 (85.00 %) had a mean ATAD2 expression level of (21.45 ± 19.69)%.Four specimens of high-grade hepatic dysplastic nodules had a mean ATAD2 expression level of (1.00±0.70) %,and no ATAD2 expression was observed in low-grade hepatic dysplastic nodules,hepatic adenoma,focal nodular hyperplasia,liver cirrhosis,and normal liver tissue.The hepatocellular carcinoma tissue had a significantly higher mean ATAD2 expression level than hepatic dysplastic nodules,hepatic adenoma,focal nodular hyperplasia,liver cirrhosis,and normal liver tissue (F=24.45,q=7.37-13.36,P<0.01),while there were no significant differences in ATAD2 expression rate and mean ATAD2 expression level between hepatocellular carcinoma tissue and cholangiocellular carcinoma tissue (P>0.05).Among the 56 surgical specimens of hepatocellular carcinoma with ATAD2 expression,52 (92.86%) had a mean expression level of ≥3%,and 50 (89.29%) had a mean expression level of ≥5%.Among the 38 surgical specimens of grade I-Ⅱ hepatocellular carcinoma,35 (92.11%) had a mean expression level of ≥1%,31 (81.58%) had a mean expression level of ≥3%,and 29 (76.32%) had a mean expression level of ≥5%.ATAD2 expression level in hepatocellular carcinoma was associated with serum alpha-fetoprotein level,presence or absence of hepatitis B surface antigens,and presence or absence of liver cirrhosis (t =2.09-2.30,P<0.05).Conclusion ATAD2 is highly expressed in hepatocellular carcinoma tissue and may play an important role in the development of hepatocellular carcinoma.It may also be involved in malignant transformation of cells.Measurement of ATAD2 expression has a high reference value in evaluating the nature of liver lesions in clinical practice.

adenosine triphosphatasescarcinoma, hepatocellularcell transformation,neoplasticimmunohistochemistry

刘芬、王彦、李宏、季惠惠、周璇、项锋钢

展开 >

青岛大学基础医学院病理学教研室,山东青岛266021

青岛大学附属医院病理科,山东青岛266021

腺苷三磷酸酶类 癌,肝细胞 细胞转化,肿瘤 免疫组织化学

国家自然科学基金资助项目2014年青岛大学附属医院青年博士基金资助项目

815023882091

2017

齐鲁医学杂志
青岛大学医学院

齐鲁医学杂志

影响因子:0.609
ISSN:1008-0341
年,卷(期):2017.32(2)
  • 2
  • 19